Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... Associated Drug(s):  Cyclophosphamide Mycophenolate Mofetil ... Cell Mobilizer Other Names: AMD3100 Mozobil(R) Drug: cyclophosphamide Given on Day -5 and Day +4 (Day 0 is first stem cell ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  2. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... Antithymocyte Globulin Cyclophosphamide Phase:  Phase ... Names: Myleran Busulfex IV Drug: Cyclophosphamide Arms A, B and C - Cytoxan will be given as a 1-2 hour ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  3. Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    ... Associated Drug(s):  Cyclophosphamide Phase:  Phase ... Total-Body Irradiation (TBI) Drug: Thiotepa Drug: Cyclophosphamide ...

    Clinical Trial last updated 04/29/2016 - 1:11pm.

  4. Total Marrow Irradiation for Refractory Acute Leukemia

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Intervention:  Drug: cyclophosphamide 60 mg/kg/day intravenous x 2 days pre-transplant, total ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  5. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Intervention:  Other: fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  6. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Fludarabine 30 mg/M2 IV on days -6 to -2 Drug: Cyclophosphamide 14.5 mg/kg IV on days -6, -5, 3, 4 Other Name: CTX ...

    Clinical Trial last updated 04/21/2016 - 1:19pm.

  7. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... Alemtuzumab Cyclophosphamide Fludarabine ... Thiotepa metabolism. Other Name: Thioplex Drug: Cyclophosphamide Cyclophosphamide (Cytoxan) should be infused over one ...

    Clinical Trial last updated 04/28/2016 - 8:36am.

  8. T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (MOHEL)

    ... Alemtuzumab Cyclophosphamide Phase:  Phase ... day-5 3 g/m2 q 12 hours Other Name: cytarabine Drug: Cyclophosphamide day-7 and day-6 45 mg/kg Other Name: Cytoxan Biological: ...

    Clinical Trial last updated 04/28/2016 - 12:15pm.

  9. Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

    ... mg/m2 as a 24 hour continuous infusion started on day -4. Cyclophosphamide 60 mg/kg/day IV given over 1 hour daily on days -3, -2. Drug: ... mg/m2 as a 24 hour continuous infusion started on day -4. Cyclophosphamide 60 mg/kg/day IV given over 1 hour daily on days -3 and ...

    Clinical Trial last updated 05/03/2016 - 11:31am.

  10. Clinical Trials Report for January 2016

    ... malignancies. Giving low doses of chemotherapy, such as cyclophosphamide and fludarabine phosphate, before a donor stem ...

    Page last updated 01/07/2016 - 10:57am.